CervoMed Inc. Deferred Income Tax Liabilities, Net
CervoMed Inc. (CRVO) had Deferred Income Tax Liabilities, Net of $0 as of 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2022-03-18
- 2021-12-31: Deferred Income Tax Liabilities, Net $0.00.
- 2021-09-30: Deferred Income Tax Liabilities, Net $0.00.
- 2021-06-30: Deferred Income Tax Liabilities, Net $443.89K.
- 2021-03-31: Deferred Income Tax Liabilities, Net $443.89K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-18 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $443.89K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $443.89K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $443.89K 10-K · filed 2022-03-18 |
| 2020-09-30 | $443.89K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.25M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.76M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.12M 10-K · filed 2021-03-17 |
| 2018-12-31 | $1.79M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |